Brain Monitoring Market: By Product, By Disease Type, Stroke, Dementia, Epilepsy, Huntington's Disease, Parkinson's Disease and Others), By End User and Clinics, Neurological Centers and Research Institutions and Others) and Region Forecast 2020-2031
Brain Monitoring Market size was valued at US$ 8.7 billion in 2024 and is expected to reach US$ 12.8 billion by 2031, growing at a significant CAGR of 5.7% from 2025-2031. A rise in incidences of brain disorders, growing awareness of neurodegenerative disorders, an increase in the geriatric population together with rising in the prevalence of chronic diseases, growing applications of brain monitoring in clinical trials, and technological advancements in brain imaging devices are some key factors fostering the market growth.
However, factors such as a lack of skilled laborers and stringent regulations for device approval are hampering the market growth. To monitor and identify brain activity, brain monitoring devices are used. The electrical and neuronal activity of the brain is monitored with the aid of brain monitoring devices. Additionally, they support the monitoring of blood flow in the brain's veins and arteries. The electrical and neurological functions of the brain are monitored and diagnosed with its assistance. The ability to display and analyze a person's neurologic problems is made possible by brain monitoring equipment.
Study Period
2025-2031Base Year
2024CAGR
5.7%Largest Market
Asia-PacificFastest Growing Market
North-America
Remarkable advances in medical diagnostic imaging have been made during the past few decades. The development of new imaging techniques and continuous improvements in the display of digital images have opened new horizons in the brain anatomy and pathology. Advanced brain imaging technology has shed new light on the neuroscience of innovation that uniquely human capacity to see a possibility that did not exist and bring it to life. The field of brain imaging has now become a fast-moving, demanding and exciting multidisciplinary activity. Rapid advances in imaging technology have made it possible to create comprehensive maps of brain structure and function, with a broad range of imaging devices, and at a variety of spatial scales.
North America accounted for a larger revenue share in the global market with considerable CAGR. The growth in this region is due to presence of the strong distribution, easy adoption of advanced technologies in healthcare systems, increasing number of the sleep and neurodegenerative disorders and huge investments made by the government to support the field of neurosciences. The Asia Pacific held substantial market share during predicted period owing to the availability of low-cost labor and skilled manpower, increase in disposable incomes and increasing government emphasis on healthcare reforms.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 8.7 billion |
|
Market Size in 2031 |
US$ 12.8 billion |
|
Market CAGR |
5.7% |
|
By Product Type |
|
|
By Disease Type |
|
|
By End user |
|
|
By Region |
|
Download Free Sample Report
The brain monitoring market size was valued at US$ 8.7 billion in 2024 and is expected to reach US$ 12.8 billion by 2031, growing at a significant CAGR of 5.7% from 2025-2031.
Natus Medical Inc, Nihon Kohden Corporation, Philips Healthcare, GE Healthcare, Siemens Healthineers
North America is the fastest-growing region in the market
| 1. Executive Summary |
| 2. Global Brain Monitoring Market Introduction |
| 2.1.Global Brain Monitoring Market - Taxonomy |
| 2.2.Global Brain Monitoring Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Disease Type |
| 2.2.3.End Users |
| 2.2.4.Region |
| 3. Global Brain Monitoring Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Brain Monitoring Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Brain Monitoring Market By Product Type , 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Device Type |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Electroencephalography (EEG) Devices |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Magnetoencephalography (MEG) Devices |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Transcranial Doppler (TCD) Devices |
| 5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Intracranial Pressure (ICP) Monitors |
| 5.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Cerebral Oximeters |
| 5.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Magnetic Resonance Imaging (MRI) Devices |
| 5.7.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 5.8. Computerized Tomography (CT) Devices |
| 5.8.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.8.3. Market Opportunity Analysis |
| 5.9. Positron Emission Tomography (PET) Devices |
| 5.9.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.9.3. Market Opportunity Analysis |
| 5.10. Sleep Monitoring Devices |
| 5.10.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.10.3. Market Opportunity Analysis |
| 5.11. Electromyography (EMG) Devices |
| 5.11.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.11.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.11.3. Market Opportunity Analysis |
| 5.12. Procedure |
| 5.12.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.12.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.12.3. Market Opportunity Analysis |
| 6. Global Brain Monitoring Market By Disease Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Traumatic Brain Injuries (TBI) |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Stroke |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Dementia |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Epilepsy |
| 6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Huntingtons Disease |
| 6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Parkinsons Disease |
| 6.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. Others |
| 6.7.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 7. Global Brain Monitoring Market By End Users, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Ambulatory Surgical Centers (ASCs) and Clinics |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Neurological Centers and Research Institutions |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Global Brain Monitoring Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. North America Brain Monitoring Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. Product Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Device Type |
| 9.1.2.Electroencephalography (EEG) Devices |
| 9.1.3.Magnetoencephalography (MEG) Devices |
| 9.1.4.Transcranial Doppler (TCD) Devices |
| 9.1.5.Intracranial Pressure (ICP) Monitors |
| 9.1.6.Cerebral Oximeters |
| 9.1.7.Magnetic Resonance Imaging (MRI) Devices |
| 9.1.8.Computerized Tomography (CT) Devices |
| 9.1.9.Positron Emission Tomography (PET) Devices |
| 9.1.10.Sleep Monitoring Devices |
| 9.1.11.Electromyography (EMG) Devices |
| 9.1.12.Procedure |
| 9.2. Invasive Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Traumatic Brain Injuries (TBI) |
| 9.2.2.Stroke |
| 9.2.3.Dementia |
| 9.2.4.Epilepsy |
| 9.2.5.Huntingtons Disease |
| 9.2.6.Parkinsons Disease |
| 9.2.7.Others |
| 9.3. End Users Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Ambulatory Surgical Centers (ASCs) and Clinics |
| 9.3.3.Neurological Centers and Research Institutions |
| 9.3.4.Others |
| 9.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10. Europe Brain Monitoring Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Device Type |
| 10.1.2.Electroencephalography (EEG) Devices |
| 10.1.3.Magnetoencephalography (MEG) Devices |
| 10.1.4.Transcranial Doppler (TCD) Devices |
| 10.1.5.Intracranial Pressure (ICP) Monitors |
| 10.1.6.Cerebral Oximeters |
| 10.1.7.Magnetic Resonance Imaging (MRI) Devices |
| 10.1.8.Computerized Tomography (CT) Devices |
| 10.1.9.Positron Emission Tomography (PET) Devices |
| 10.1.10.Sleep Monitoring Devices |
| 10.1.11.Electromyography (EMG) Devices |
| 10.1.12.Procedure |
| 10.2. Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Traumatic Brain Injuries (TBI) |
| 10.2.2.Stroke |
| 10.2.3.Dementia |
| 10.2.4.Epilepsy |
| 10.2.5.Huntingtons Disease |
| 10.2.6.Parkinsons Disease |
| 10.2.7.Others |
| 10.3. End Users Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Ambulatory Surgical Centers (ASCs) and Clinics |
| 10.3.3.Neurological Centers and Research Institutions |
| 10.3.4.Others |
| 10.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11. Asia Pacific (APAC) Brain Monitoring Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Device Type |
| 11.1.2.Electroencephalography (EEG) Devices |
| 11.1.3.Magnetoencephalography (MEG) Devices |
| 11.1.4.Transcranial Doppler (TCD) Devices |
| 11.1.5.Intracranial Pressure (ICP) Monitors |
| 11.1.6.Cerebral Oximeters |
| 11.1.7.Magnetic Resonance Imaging (MRI) Devices |
| 11.1.8.Computerized Tomography (CT) Devices |
| 11.1.9.Positron Emission Tomography (PET) Devices |
| 11.1.10.Sleep Monitoring Devices |
| 11.1.11.Electromyography (EMG) Devices |
| 11.1.12.Procedure |
| 11.2. Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Traumatic Brain Injuries (TBI) |
| 11.2.2.Stroke |
| 11.2.3.Dementia |
| 11.2.4.Epilepsy |
| 11.2.5.Huntingtons Disease |
| 11.2.6.Parkinsons Disease |
| 11.2.7.Others |
| 11.3. End Users Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Ambulatory Surgical Centers (ASCs) and Clinics |
| 11.3.3.Neurological Centers and Research Institutions |
| 11.3.4.Others |
| 11.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12. Middle East and Africa (MEA) Brain Monitoring Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Device Type |
| 12.1.2.Electroencephalography (EEG) Devices |
| 12.1.3.Magnetoencephalography (MEG) Devices |
| 12.1.4.Transcranial Doppler (TCD) Devices |
| 12.1.5.Intracranial Pressure (ICP) Monitors |
| 12.1.6.Cerebral Oximeters |
| 12.1.7.Magnetic Resonance Imaging (MRI) Devices |
| 12.1.8.Computerized Tomography (CT) Devices |
| 12.1.9.Positron Emission Tomography (PET) Devices |
| 12.1.10.Sleep Monitoring Devices |
| 12.1.11.Electromyography (EMG) Devices |
| 12.1.12.Procedure |
| 12.2. Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Traumatic Brain Injuries (TBI) |
| 12.2.2.Stroke |
| 12.2.3.Dementia |
| 12.2.4.Epilepsy |
| 12.2.5.Huntingtons Disease |
| 12.2.6.Parkinsons Disease |
| 12.2.7.Others |
| 12.3. End Users Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Ambulatory Surgical Centers (ASCs) and Clinics |
| 12.3.3.Neurological Centers and Research Institutions |
| 12.3.4.Others |
| 12.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13. Latin America Brain Monitoring Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Device Type |
| 13.1.2.Electroencephalography (EEG) Devices |
| 13.1.3.Magnetoencephalography (MEG) Devices |
| 13.1.4.Transcranial Doppler (TCD) Devices |
| 13.1.5.Intracranial Pressure (ICP) Monitors |
| 13.1.6.Cerebral Oximeters |
| 13.1.7.Magnetic Resonance Imaging (MRI) Devices |
| 13.1.8.Computerized Tomography (CT) Devices |
| 13.1.9.Positron Emission Tomography (PET) Devices |
| 13.1.10.Sleep Monitoring Devices |
| 13.1.11.Electromyography (EMG) Devices |
| 13.1.12.Procedure |
| 13.2. Disease Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Traumatic Brain Injuries (TBI) |
| 13.2.2.Stroke |
| 13.2.3.Dementia |
| 13.2.4.Epilepsy |
| 13.2.5.Huntingtons Disease |
| 13.2.6.Parkinsons Disease |
| 13.2.7.Others |
| 13.3. End Users Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Ambulatory Surgical Centers (ASCs) and Clinics |
| 13.3.3.Neurological Centers and Research Institutions |
| 13.3.4.Others |
| 13.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Natus Medical Inc. (U.S.) |
| 14.2.2.Nihon Kohden Corporation (Japan) |
| 14.2.3.Philips Healthcare (Netherlands) |
| 14.2.4.GE Healthcare (U.K.) |
| 14.2.5.Siemens Healthineers (Germany) |
| 14.2.6.Compumedics Ltd. (Australia) |
| 14.2.7.Electrical Geodesics Incorporated (U.S.) |
| 14.2.8.Medtronic plc (Ireland) |
| 14.2.9.CAS Medical Systems, Inc. (U.S.) |
| 14.2.10.Advanced Brain Monitoring (U.S.) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Sample
